Northwest & Ethical Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-600	Closed	-$73.8K	–	396
2018 Q3	$73.8K	Sell	600 -600	-50%	-$73.8K	﹤0.01%	344
2018 Q2	$118K	Buy	1,200 +100	+9%	+$9.82K	0.01%	346
2018 Q1	$91.2K	Buy	+1,100	New	+$91.2K	0.01%	344